Understanding Phibro (PAHC) Reliance on International Revenue

Phibro Animal Health (PAHC) reported Q2 2026 total revenue of $396.7 million, up 4.8% year-over-year. International markets contributed significantly, with Latin America and Canada delivering a notable 26.37% revenue surprise at $90.22 million. The company holds a Zacks Rank #3 (Hold) rating, with analysts projecting full-year revenue of $1.57 billion, up 3.7% annually. Stock performance has lagged the broader market over the past month but outperformed over three months.